Navigation Links
Dominion Diagnostics to Sponsor 2013 Addiction Professional Panel Series as Thought Leadership Partner
Date:3/26/2013

NORTH KINGSTOWN, R.I., March 26, 2013 /PRNewswire/ -- Dominion Diagnostics, a leading national provider of clinical drug testing and medication monitoring services, will sponsor a year-long series of regional educational Lunch'n'Learns hosted by Addiction Professional, a magazine published for the addiction treatment field by Vendome Healthcare Media.

Dominion Diagnostics has been designated by Addiction Professional as a Thought Leadership Partner for 2013.  As a lead sponsor and designated partner, Dominion will participate in each event in the educational series.  Each panel in the series will feature thought leaders and experts from the addiction treatment and behavioral health fields discussing critical topics in managing addiction treatment today.

A number of the 2013 series featured panelists are members of Dominion's Addiction Medicine Advisory Board, an assembly of 14 recognized thought leaders with vast experience in the addiction medicine field. The Board focuses on collaborative research, developing and delivering educational curricula, and understanding field trends to assist Dominion in designing clinically relevant products and services for addiction treatment providers. 

"For more than 16 years, Dominion Diagnostics has demonstrated an ongoing commitment to the recovery community and a dedication to advancing patient care and improving outcomes by supporting treatment with state-of-the-art laboratory science," said David E. Smith , MD of San Francisco, California. "Dominion is the precise thought leadership partner to promote education for addiction treatment providers in the field today." 

Dr. Smith is well-known in the field for establishing the Haight-Ashbury Free Medical Clinics in 1967. Dr. Smith is also a past president of the American Society of Addiction Medicine, a current participant in the San Francisco Medical Society Committee on the Well-Being of Physicians, and a member of Dominion's Addiction Medicine Advisory Board.

The 2013 Addiction Professional Panel Series, which will include up to nine lunch and learn educational events, will kick off in March with programs in Dallas, Texas (March 27) and Anaheim, California (March 28).  The panel discussion topic for both March events is Building a Recovery-Oriented System of Care.    

Registration is now open at:

About Dominion Diagnostics

Dominion Diagnostics is a leading national provider of clinical drug testing, medication monitoring services, and a full suite of clinical support solutions. Since 1997, Dominion Diagnostics has provided services to thousands of clients representing a diversity of medical specialties across the United States, including addiction medicine, behavioral health, pain medicine, primary care, psychiatry, and hospital systems. Dominion Diagnostics is supported by a world-class team that shares a commitment to clinical excellence, compliance, and integrity. For more information, please visit www.dominiondiagnostics.com.

About Addiction Professional

Addiction Professional's mission is to assist counselors, medical staff, supervisors, and other key decision makers at addiction treatment and prevention organizations in their pursuit of clinical excellence. Reporting on the whole spectrum of addictions and addiction treatment services, Addiction Professional provides timely guidance on care delivery, management strategies, and emerging trends affecting addiction services in the public and private sectors.  Addiction Professional is part of group of high-quality publications published by Vendome Healthcare Media for professionals in the Behavioral Health and Addiction Treatment fields.  Additional, Vendome produces the National Conference on Addiction Disorders each September, a premiere event that aims to supply both clinical and managerial strategies designed to improve the quality of life for addiction treatment and behavioral health patients. For more information, please visit www.addictionpro.com.

Media contact: Leigh Melanson , 401-667-0837, lmelanson@dominiondiagnostics.com 


'/>"/>
SOURCE Dominion Diagnostics, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Quest Diagnostics CE Marks Simplexa™ Test for Cytomegalovirus for Sale in Europe
2. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
3. Acumen Pharmaceuticals Regains Worldwide Rights to Anti-ADDL Antibody Therapeutics and Diagnostics for Alzheimers Disease From Merck
4. S.E.D. Labs to be Acquired by Quest Diagnostics
5. SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 During JP Morgan Healthcare Conference January 9 - 12
6. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
7. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
8. India In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture
9. Boulder Diagnostics Licenses Novel Rapid Detection Technology for Homocysteine and Related Compounds from Portland State University
10. Quest Diagnostics STRATIFY JCV™ First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients
11. Quest Diagnostics Reports Fourth Quarter 2011 Financial Results; Provides Guidance for 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... ... development of precision treatments for neurodegenerative diseases, today announced the validated monoclonal ... the direct neurotoxic effect of prion-like forms of Amyloid beta (Aß) in ...
(Date:12/5/2016)... Research and Markets has announced the addition of Jain PharmaBiotech,s ... their offering. ... This report describes different types ... proteomics and metabolomics. Molecular diagnostics technologies are used for the discovery ... Currently the most important applications of biomarkers are in drug ...
(Date:12/5/2016)...  Renova™ Therapeutics, a biotechnology company developing gene ... chronic diseases, announced that Catherine Bovenizer , ... Officer (CFO), effective today. Ms. Bovenizer ... in financial management for a variety of public ... recently, Ms. Bovenizer was the Vice President of ...
(Date:12/5/2016)... Research and Markets has announced the addition of ... and Companies" to their offering. ... , , ... variations, development of sequencing technologies, and their applications. Current large ... them. Various applications of sequencing are described including those for ...
Breaking Biology Technology:
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:11/14/2016)... Calif. , Nov. 14, 2016 /PRNewswire/ ... biometric identification market, Frost & Sullivan recognizes ... & Sullivan Award for Visionary Innovation Leadership. ... in the biometric identification market by pioneering ... verification solution for instant, seamless, and non-invasive ...
(Date:6/22/2016)... LOS ANGELES , June 22, 2016 ... of identity management and verification solutions, has ... cutting edge software solutions for Visitor Management, ... ® provides products that add functional ... The partnership provides corporations and venues with ...
Breaking Biology News(10 mins):